A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Exactech and Bodycad Sign Exclusive Distribution Agreement – To Offer Personalized Unicompartmental Knee Replacement

November 24, 2020

Exactech announced today the signing of an exclusive distribution agreement with orthopaedic manufacturer Bodycad for its Reflex Uni™ knee in the U.S.

This new product offering expands Exactech’s Truliant® primary and revision knee system to include a personalized unicompartmental implant that is designed to fit each patient’s unique anatomy. Truliant Reflex Uni is the latest addition to Exactech’s Active Intelligence® technology platform of personalized, data-driven solutions designed to improve patient outcomes.

Leveraging the latest in 3D printing technology, Truliant Reflex Uni was developed by Bodycad using a proprietary software algorithm and a fully integrated production system. Bodycad has developed an innovative 3D image rendering, digital planning, and production system to optimize personalized restoration of each patient’s anatomy. Bodycad’s proprietary software serves as the digital backbone to highly automate all processes.

The resulting patient-specific unicompartmental knee replacement requires no off-the-shelf implants and minimal instrumentation, making it ideally suited for an efficient hospital or ambulatory surgery center. In addition, Truliant Reflex Uni offers patients a better fit and potential for improved clinical results and satisfaction.

“Innovation in unicompartmental knee implants has been stagnant for years,” said John McDaniel, Exactech’s Senior Vice President, Large Joints. “We intentionally delayed offering a partial knee until we had something that could address the shortcomings of existing designs. With Truliant Reflex Uni, surgeons have the option to change implant design and placement to meet the needs of each patient. We’re excited about this personalized solution and its potential to maximize bone coverage, achieve proper alignment, and optimize joint function.”

“Bodycad’s indisputable expertise in the computer design of personalized unicompartmental prostheses united with the knowledgeable US sales force of Exactech is a union which will allow us to raise the success of a personalized joint restoration,” said CEO and Founder of Bodycad Jean Robichaud.

The Truliant Knee System is an award-winning platform of implants, instruments and technology that helps surgeons achieve reproducibility and efficiency in primary and revision knee arthroplasty. Exactech’s Active Intelligence portfolio connects surgeons and patients with smart decisions throughout the journey of care.

SourceExactech
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy